For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved

Guide

How to vet a research compound supplier

A due-diligence checklist for comparing research compound vendors: what a lot-specific COA must disclose, why purity and net peptide content differ, and what a weak certificate looks like.

To vet a research compound supplier, work backwards from one object: the certificate of analysis for the exact lot that would arrive in your box. The practical question — how do you vet a peptide supplier — reduces to whether you can take a lot number off a physical vial, resolve it to a certificate on the vendor’s own domain, and find six things on it: a named testing laboratory, a test date, a confirmed identity, a purity result with its method, a net peptide content figure, and a microbial result. A supplier producing all six for the lot in your hand is running a quality system. A supplier offering a “99% pure” badge is offering a claim in place of a record. Apply what follows to us as readily as to anyone else.

Start from the lot, not the brand

Compounds are manufactured in discrete batches, and every batch is chemically distinct. Coupling efficiency drifts, resin lots differ, purification gradients get retuned. A certificate describes one batch on one day and says nothing about the next. This is why batch identity anchors serious manufacturing frameworks: ICH Q7, the international good-manufacturing-practice guide for active pharmaceutical ingredients, treats a unique batch number plus retained records as the minimum unit of traceability, and 21 CFR 211.194 requires laboratory records to hold complete data from every test run on a batch.

The first question is therefore narrow and answerable: which lot ships today, and can I see that lot’s certificate before I order? Some vendors publish every lot in advance; some send a lot-specific certificate on request; some send the same document they sent last year. Only the first two are verifiable, and only the first lets you compare this lot’s impurity profile against the last. A line-by-line walkthrough of the document is in how to verify a certificate of analysis.

What a complete certificate discloses

A useful certificate is a set of measurements, each with a method attached. Use this as a peptide supplier checklist when comparing two vendors’ documents.

AttributeQuestion it answersWhat should appear on the certificate
IdentityIs it actually the named molecule?Mass spectrometry against the theoretical mass for the sequence
PurityWhat fraction of detected material is the main peak?HPLC percentage plus the method block: column, gradient, wavelength
Net peptide contentHow much of the powder is peptide?A separate assay, commonly amino acid analysis, as % w/w
CounterionWhat salt form occupies the remaining mass?Counterion named (typically trifluoroacetate or acetate) with its content
Water contentHow much moisture survived lyophilization?Karl Fischer, % w/w
Microbial qualityAre bioburden and endotoxin controlled?USP <61>/<62> counts and a USP <85> endotoxin value in EU/mg
ReleaseWho takes responsibility for these numbers?Named laboratory, test date, signature or authorized release

Few certificates in this market carry all seven rows. The point is not to disqualify a vendor for an incomplete document, but to know which questions it leaves open.

Purity, counterion and net peptide content are three different numbers

This is the most useful distinction a buyer can learn, and most vendors publish only the first. HPLC purity is a ratio of peak areas: of everything the detector saw, what percentage was the main peak? It says nothing about how much of the vial’s mass is peptide.

Peptide purified by reverse-phase chromatography and then lyophilized arrives as a salt. Residual water and counterion — commonly trifluoroacetate, carried over from the mobile phase — occupy real mass in the vial. Net peptide content is the separate measurement that resolves this: a lot can be 99% pure by HPLC while a meaningful fraction of the powder by weight is water and salt. A certificate reporting purity but no peptide content leaves the mass in the vial unquantified.

The counterion matters for a second reason: it is not inert in every experimental system, and some assays are sensitive to which salt form they are handed. A vendor who names and quantifies it lets you decide. Why the purity figure itself deserves interrogation is covered in the case for a 99% purity floor.

Microbial quality is a separate question from purity

Chromatography is not a test for bacteria, fungi or bacterial endotoxin. None of them register as a resolved peak on a routine purity trace, so a 99.5% purity result carries no information about any of them. Each has its own compendial method: USP <61> and <62> for microbial enumeration and specified organisms, USP <85> for bacterial endotoxins, USP <71> for sterility where sterility is claimed. Residual process solvents are governed separately under ICH Q3C and are likewise invisible to a purity assay.

Ask whether microbial quality appears on the certificate at all. Many research-compound certificates cover identity and purity and stop — a disclosure gap rather than a scandal. But a vendor claiming sterility with no USP <71> result has made a claim their own document does not support.

What a weak certificate looks like

Weak certificates fail in recognizable ways. Each of these is a reason to ask a follow-up question, not to assume bad faith:

  • A lot number that does not match the vial, or none at all. The document is no longer attached to the material, which makes every other line irrelevant.
  • A “typical values” header, or one certificate serving a whole product line. That is a specification sheet: what the product is supposed to be, not what this batch measured.
  • A purity percentage with no method block. No column, no gradient, no wavelength means the number cannot be reproduced or compared against another lab’s figure.
  • No instrument trace. A results table without the chromatogram hides the integration choices behind the number, which is why we publish the chromatogram rather than the headline.
  • An unnamed lab, or an unsigned and undated document. “Third-party tested” is a phrase, not a referent you can check; without a date the result cannot be placed against the manufacture date, and without a signature nobody has accepted responsibility.
  • Identical figures across every lot. Real assays scatter. Every batch landing on exactly 99.0% is a template, not a measurement.
  • A flat image sent by email. Image files are trivially editable. Prefer a document you reached yourself from the lot number.

Traceability, publication posture and cold chain

First, traceability: can you get from the vial in your hand back to the certificate without the vendor’s help? A label code that resolves to a lot record is traceability; an emailed PDF is not. Every Merit lot resolves this way, and you can verify any lot’s certificate from its number.

Second, publication posture. Publishing every lot in advance is a different commitment from producing one on request: it removes the vendor’s ability to choose which result you see. It also lets you compare batch to batch, which matters most where synthesis length drives the truncation profile — a 39-residue chain like tirzepatide offers far more opportunity for failed couplings than a 15-residue peptide such as BPC-157.

Third, cold chain. Ask how the vendor packs, what transit time they design for, and what happens when a package arrives warm. Lyophilized material is generally far more stable than material in solution — the framework for stability expectations is ICH Q1A(R2) — but robustness is not a reason to skip the question. What to check in the first fifteen minutes after delivery is set out in cold-chain handling. Merit ships from San Antonio; whoever you buy from, what matters is the transit window and the replacement policy.

A ten-minute checklist for how to vet a peptide supplier

  1. Ask which lot ships today, and request that lot’s certificate before ordering.
  2. Check that it names the testing laboratory and carries a date and a signature.
  3. Confirm identity is reported, not only purity — a vial can be 99% pure and the wrong molecule.
  4. Check whether the purity method is stated in full and a chromatogram is shown.
  5. Look for net peptide content and a named counterion. If absent, ask what fraction of the vial mass is peptide.
  6. Look for any microbial or endotoxin result, and match it against what the vendor claims.
  7. Ask whether every lot is published, and whether past lots stay accessible.
  8. Ask how material ships and what happens if it arrives warm.
  9. On arrival, compare the vial’s lot number to the certificate first.
  10. If the work justifies it, send your own sample to an independent lab.

A reputable peptide supplier is identifiable by the specificity of what they will put in writing about one batch, not by the confidence of what they say about their products in general. Purity, identity, peptide content and microbial quality are four separate measurements, and a vendor who answers all four for the lot in front of you has made themselves checkable. Everything else — the branding, the badge, the unattributed promise of third-party testing — is a claim you cannot resolve.

All materials discussed are supplied for laboratory and scientific research use only — not for human or veterinary use, and not FDA-approved. Nothing here is guidance on preparing, administering, or using any compound.

For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.